Ligand- and species-dependent activation of PPARα

Cellular Physiology and Biochemistry

Volumn 14, Issue 4-6, 2004, Pages 269-276

  Akbiyik, Filiz ^a,b   Ray, Denise M ^b   Bozkaya, Hakan ^c   Demirpence, Ediz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF ROCHESTER   (United States)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Clofibrate; Hepatoma cell line; Linoleic acid; PPAR DNA binding; PPAR expression

Indexed keywords

CLOFIBRATE; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; WESTERN BLOTTING;

EID: 3042775526     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080336     Document Type: Article

References (36)

1. Kliewer SA, Xu HE, Lambert MH, Willson TM: Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 2001;56:239-263.
2. Berger J, Moler DE: The mechanism of action of PPARs. Annu Rev Med 2002;53:409-435.
3. Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA, Desvergne B: DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′ flanking region. J Biol Chem 1997;272:25252-25259.
4. Vega RB, Huss JM, Kelly DP: The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000;20:1868-1876.
5. Mukherjee R, Sun S, Santomenna, Miao B, Walton H, Liao B, Locke K, Zhang J-H, Nguyen SH, Zhang LT, Murphy K, Ross HO, Xia MX, Teleha C, Chen S-Y, Selling B, Wynn R, Burn T, Young PR: Ligand and coactivator recruitment preferences of peroxisome proliferator-activated receptor α???J Steroid Biochem Molec Biol 2002;81:217-225.
6. Issemann I, Green S: Activation of member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
7. Nelson DL, Cox MC: Oxidation of fatty acids. In: Lehninger Principles of Biochemistry, Worth Publishers, New York, 2000, pp 598-622.
8. Green S: Peroxisome proliferators: A model for receptor mediated carcinogenesis. Cancer Surv 1992;14:221-232.
9. Yeldandi AV, Rao MS, Reddy JK: Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mut Res 2000;448:159-177.
10. Karpen SJ: Nuclear receptor regulation of hepatic function. J Hepatol 2002;36:832-850.
11. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA: Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995;270:23975-23983.
12. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W: Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay. Mol Endocrinol 1997;11:779-791.
13. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 1997;94:4312-4317.
14. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 1997;94:4318-4323.
15. Green S: PPAR: a mediator of peroxisome proliferator action. Mutat Res 1995;333:101-109.
16. Akbiyik F, Cinar K, Ozsullu T, Demirpence E, Tunca R, Haziroglu R, Onder O, Civris S, Yurdaydin C, Uzunalimoglu O, Bozkaya H: Peroxisome proliferator activated receptor-alpha (PPAR-alpha) expression is induced but peroxisomal enzyme response to clofibrate is blunted in a rat model of fatty liver. J Hepatol 2003;38:84.
17. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203-210.
18. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19:2499.
19. Suchanek KM, May F, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ: Peroxisome proliferator-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinogen 2002;34:165-171.
20. Inoue I, Shino K, Noji S, Awata T, Katayama S: Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cell. Biochem Biophys Res Commun 1998;246:370-374.
21. Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA: Conjugated linoleic acid is a potent naturally occuring ligand and activator of PPARα. J Lipid Res 1999;40:1426-1433.
22. Edgar AD, Tomkiewicz C, Costet P, Legendre C, Aggerbeck M, Bouguet J, Staels B, Guyomard C, Pineau T, Barouki R: Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. Toxicol Lett 1998;98:13-23.
23. Linden D, Lindberg K, Oscarsson J, Claesson C, Asp L, Li L, Gustafsson M, Boren J, Olofsson S-O: Influence of peroxisome proliferator-activated receptor α agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 2002;277:23044-23053.
24. Hsu M-H, Savas U, Griffin KJ, Johnson EF: Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in Hep G2 cells. J Biol Chem 2001;276:27950-27958.
25. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-688.
26. Green S, Tugwood J, Issemann I: The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment. Toxicol Lett 1992;64/65:131-139.
27. Choudhury AI, Chahal S, Bell AR, Tomlinson SR, Roberts RA, Salter AM, Bell DR: Species differences in peroxisome proliferation; mechanisms and relevance. Mut Res 2000;448:201-212.
28. Mukherjee R, Jow L, Noonan D, McDonnell DP: Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol 1994;51:157-166.
29. Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G: Differential regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α. J Biol Chem 2001;276:31521-31527.
30. Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD, Moore JT, Willson TM: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 2001;98:13919-13924.
31. Takada I, Yu RT, Xu HE, Lambert MH, Montana VG, Kliewer SA, Evans RM, Umesono K: Alteration of a single amino acid in peroxisome proliferator- activated receptor-α (PPARα) generates a PPARδ phenotype. Mol Endocrinol 2000;14:733-740.
32. Li Y, Lambert MH, Xu HE: Activation of nuclear receptors: a perspective from structural genomics. Structure 2003;11:741-745.
33. Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, Stimmel JB: Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Biochemistry 2003;42:9278-9287.
34. Duplus E, Glorian M, Forest C: Fatty acid regulation of gene transcription. J Biol Chem 2000;275:30749-30752.
35. Qu B, Li QT, Wong KP, Tan TM, Halliwell B: Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radic Biol Med 2001;31:659-669.
36. Nagai MK, Farber E: The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate. Exp Mol Pathol 1999;67:144-149.